HomeNewsGlobal Pharma

Porus Labs Welcomes Radhesh Welling as CEO in Strategic Partnership with Bain Capital

Porus Labs Welcomes Radhesh Welling as CEO in Strategic Partnership with Bain Capital

Porus Labs has unveiled a pivotal chapter in its journey with the announcement of a strategic partnership with Radhesh Welling. Welling is set to join the company's board and assume the role of Chief Executive Officer (CEO), leveraging his nearly thirty-year track record of leadership in innovative, high-performance specialty chemicals companies globally.

Having previously served as the Managing Director and Group CEO at Navin Fluorine since 2018, Welling brings a wealth of experience to Porus Labs. During his tenure at Navin Fluorine, he played a crucial role in formulating and executing strategic expansion plans, resulting in significant growth over the last five years. His international experience also includes working with J.M.Huber Corporation in the United States.

In a statement, Welling expressed his excitement about joining Porus Labs. “I am delighted to join Porus Labs, a true multi-generational business renowned for its innovation and leadership in contract manufacturing and speciality chemicals. This is a once-great opportunity to partner with Bain Capital to deliver immense value to our international customers,” he said. 

"Speciality chemicals is a unique and complex industry, and we’re thrilled to partner with an experienced leader like Radhesh to help realize the company’s global growth aspirations," commented Pawan Singh and Rishi Mandawat, Partners at Bain Capital. They emphasized the alignment in vision for Porus Labs and the shared opportunities for organic growth and acquisitions.

Established in 1994 in Hyderabad, Porus Labs has undergone a transformative journey from a single manufacturing unit for Sulpha-based drugs to a key player supporting domestic API manufacturers and expanding agro-chemical capabilities. The company's commitment to innovation and adaptability is evident in its growth trajectory, reflecting its ability to meet the evolving demands of the industry.

The partnership with Radhesh Welling and Bain Capital marks a strategic inflection point for Porus Labs, signifying a concerted effort to drive growth in new products and chemistries that cater to both existing and new customers. 

Read more on:
More news about: global pharma | Published by Manvi | January - 02 - 2024 | 2696

Last news about this category


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members